After the merger, AAH was expected to have $167mil in cash and 235mil shares on issue, so that's cash value of $0.71
Add to that the $17.7mil recently received, less running costs since the merger, add the $100+mil expected in from the current patents until they expire in 2010... gives a cash value (before discounting and other running costs) of around $1.20.
So it's pretty much trading below cash value right now!
- Forums
- ASX - By Stock
- AAH
- another 17.7 million
AAH
arana therapeutics limited
another 17.7 million, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)